Xylem Inc.
XYL
$122.85
-$0.46-0.37%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 2.07B | 2.26B | 2.10B | 2.17B | 2.03B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.07B | 2.26B | 2.10B | 2.17B | 2.03B |
| Cost of Revenue | 1.30B | 1.40B | 1.32B | 1.35B | 1.28B |
| Gross Profit | 768.00M | 857.00M | 784.00M | 819.00M | 752.00M |
| SG&A Expenses | 461.00M | 455.00M | 445.00M | 486.00M | 475.00M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.82B | 1.91B | 1.82B | 1.89B | 1.82B |
| Operating Income | 251.00M | 344.00M | 284.00M | 275.00M | 218.00M |
| Income Before Tax | 217.00M | 375.00M | 269.00M | 247.00M | 196.00M |
| Income Tax Expenses | 50.00M | 49.00M | 52.00M | 53.00M | 43.00M |
| Earnings from Continuing Operations | 167.00M | 326.00M | 217.00M | 194.00M | 153.00M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 2.00M | -- | -- | -- | -- |
| Net Income | 169.00M | 326.00M | 217.00M | 194.00M | 153.00M |
| EBIT | 251.00M | 344.00M | 284.00M | 275.00M | 218.00M |
| EBITDA | 396.00M | 486.00M | 425.00M | 420.00M | 352.00M |
| EPS Basic | 0.70 | 1.34 | 0.89 | 0.80 | 0.63 |
| Normalized Basic EPS | 0.65 | 0.87 | 0.71 | 0.69 | 0.55 |
| EPS Diluted | 0.69 | 1.33 | 0.89 | 0.80 | 0.63 |
| Normalized Diluted EPS | 0.64 | 0.87 | 0.71 | 0.69 | 0.54 |
| Average Basic Shares Outstanding | 243.11M | 242.97M | 242.93M | 242.57M | 241.85M |
| Average Diluted Shares Outstanding | 243.78M | 243.77M | 243.75M | 243.54M | 243.02M |
| Dividend Per Share | 0.40 | 0.36 | 0.36 | 0.36 | 0.36 |
| Payout Ratio | 57.99% | 26.69% | 40.55% | 44.85% | 57.52% |